RA
CSTL icon

Royce & Associates’s Castle Biosciences CSTL Stock Holding History

Royce & Associates’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,365
Closed -$334K – 872
2024
Q2 		$334K Buy
15,365
+4,240
+38% +$94.5K ﹤0.01% 818
2024
Q1 		$246K Sell
11,125
-20,517
-65% -$446K ﹤0.01% 821
2023
Q4 		$683K Buy
31,642
+8,833
+39% +$155K 0.01% 768
2023
Q3 		$385K Buy
+22,809
New +$399K ﹤0.01% 833
2021
Q1 		– Sell
-35,000
Closed -$2.35M – 1021
2020
Q4 		$2.35M Sell
35,000
-481
-1% -$26.1K 0.02% 693
2020
Q3 		$1.82M Buy
35,481
+6,481
+22% +$288K 0.02% 695
2020
Q2 		$1.09M Buy
+29,000
New +$991K 0.01% 761

Other funds holding CSTL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return